4//SEC Filing
Oliveto Joseph 4
Accession 0001437782-26-000002
CIK 0001408443other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:53 PM ET
Size
6.9 KB
Accession
0001437782-26-000002
Insider Transaction Report
Form 4
Oliveto Joseph
DirectorPresident and CEO
Transactions
- Sale
Common Shares
2026-01-07$2.25/sh−500$1,125→ 346,721 total - Sale
Common Shares
2026-01-08$2.25/sh−43,000$96,750→ 303,721 total
Footnotes (2)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.265 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Milestone Pharmaceuticals Inc.
CIK 0001408443
Entity typeother
Related Parties
1- filerCIK 0001437782
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:53 PM ET
- Size
- 6.9 KB